EI
MRVI icon

Ethic Inc’s Maravai LifeSciences MRVI Stock Holding History

Ethic Inc’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.2K Sell
10,604
-1,333
-11% -$5.75K ﹤0.01% 1344
2026
Q1 		$33.8K Sell
11,937
-826
-6% -$2.8K ﹤0.01% 1222
2025
Q4 		$41.5K Sell
12,763
-4,188
-25% -$14.1K ﹤0.01% 1195
2025
Q3 		$48.6K Buy
16,951
+6,540
+63% +$16.7K ﹤0.01% 1179
2025
Q2 		$25.7K Buy
+10,411
New +$21.9K ﹤0.01% 1203
2024
Q4 		– Sell
-13,896
Closed -$120K – 1198
2024
Q3 		$120K Buy
13,896
+3,451
+33% +$29.8K ﹤0.01% 1032
2024
Q2 		$74.8K Sell
10,445
-3,451
-25% -$29.8K ﹤0.01% 1085
2024
Q1 		$120K Buy
13,896
+2,417
+21% +$16.4K ﹤0.01% 1032
2023
Q4 		$75.2K Buy
+11,479
New +$74.2K ﹤0.01% 1031
2023
Q2 		– Sell
-12,623
Closed -$177K – 1003
2023
Q1 		$177K Buy
12,623
+2,434
+24% +$35K 0.01% 906
2022
Q4 		$146K Buy
+10,189
New +$160K 0.01% 853

Other funds holding MRVI

DRP
Decker Retirement Planning Levi, Utah $294M AUM 97.44% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.15B AUM 70.1% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Ethic Inc's MRVI Position: Q2 2026 in Review

Ethic Inc reduced its Maravai LifeSciences (MRVI) stake by 11% in Q2 2026, selling an estimated $5.75K and leaving 10,604 shares worth $66.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1344.

Ethic Inc first reported a position in MRVI in Q4 2022 and has held it in 11 quarters since. The position peaked at $177K in Q1 2023. 19 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Ethic Inc held 10,604 shares of Maravai LifeSciences worth $66.2K as of Q2 2026.
  • Ethic Inc sold 1,333 Maravai LifeSciences shares in Q2 2026, an estimated $5.75K.
  • Maravai LifeSciences made up ﹤0.01% of Ethic Inc's portfolio in Q2 2026, its #1344 holding.
  • Ethic Inc first reported a position in Maravai LifeSciences in Q4 2022 and has held it in 11 quarters since.
  • Ethic Inc's Maravai LifeSciences position peaked at $177K in Q1 2023.
  • 19 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.